pharma · Acute Cannabinoid Intoxication · ANEB
Anebulo Pharmaceuticals
Anebulo Pharmaceuticals is a pharma organization headquartered in Austin, USA. It trades on NYSE under ticker ANEB. Primary therapeutic focus areas include Acute Cannabinoid Intoxication. NovaPharmaNews links 2 clinical
Austin, USA HQ
10 Employees
Public company Type
ANEB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Austin, USA
- Employees
- 10
- Programs
- 2
- Drugs
- 0
- Patents
- 1
ANEB-001
Phase 2 · small molecule · Acute Cannabinoid Intoxication
ANEB-001 for Acute Cannabinoid Intoxication is a Phase 2 program (small_molecule) at Anebulo Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code AN01AC11
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Anebulo Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Acute Cannabinoid Intoxication
- Status
- completed
- Trials
- 1